Back to YC Companies
Modulari-T
Winter 2023
Active
We teach your immune system to attack and cure cancer
4 people View on YC
Modulari-T at a glance
- Y Combinator batch
- Winter 2023
- Status
- Active
- Industry
- Healthcare
- Team size
- 4 people
- Location
- Not recorded
- Website
- Not recorded
Every field above comes from the Y Combinator company record. Nothing is estimated.
About Modulari-T
Cell and gene therapy promises to one day cure any disease; Modulari-T’s Platform produces the tools to fulfill that promise. Modulari-T has designed a new family of synthetic genes that can reprogram cells to better sense their environment and modify their behavior accordingly. This can be used to engineer immune cells to efficiently recognize and kill cancer cells or to create stem cells able to regenerate any tissue. Modulari-T looks to expand its technology to reach every area of cell therapy and become the platform of reference for cell engineering.
Tags:
Gene Therapy
Cell Therapy
Synthetic Biology
Biotech
Oncology